IVERIC bio Inc (ISEE)
US46583P1021 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 467.57M | 476.30M | 261.45M | 66.40M | 125.70M | |||
| Marketable Securities | 132.35M | 170.53M | 120.30M | 143.70M | N/A | |||
| Receivables | N/A | N/A | 0.00 | 1.80M | 900.00K | |||
| Other Current Assets | 11.62M | 15.99M | 5.74M | 4.80M | 2.00M | |||
| Total Current Assets | 611.54M | 662.83M | 387.49M | 216.60M | 128.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.86M | 2.13M | 1.87M | 100.00K | 700.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 1.87M | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 1.86M | 4.00M | 1.87M | 200.00K | 1.60M | |||
| TOTAL ASSETS | 613.41M | 666.82M | 389.36M | 216.80M | 130.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 21.35M | 12.74M | 15.36M | 12.30M | 7.40M | |||
| Accounts Payable | 18.03M | 22.84M | 12.86M | 12.80M | 5.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 39.37M | 35.59M | 28.21M | 25.10M | 13.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 96.99M | 96.57M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 11.00K | 619.00K | 100.00K | N/A | |||
| Total Non-Current Liabilities | 96.99M | 96.58M | 619.00K | 100.00K | 0.00 | |||
| TOTAL LIABILITIES | 136.36M | 132.17M | 28.83M | 25.20M | 13.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -937.03M | -864.81M | -679.60M | -565.10M | -480.50M | |||
| Additional Paid In Capital | 1.41B | 1.40B | 1.04B | 756.50M | 597.70M | |||
| Common Shares | 137.00K | 137.00K | 115.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -99.00K | -229.00K | -90.00K | 0.00 | N/A | |||
| Shares Outstanding | 137.25M | 136.64M | 115.28M | 90.10M | 49.60M | |||
| Tangible Book Value per Share | 3.48 | 3.91 | 3.13 | 2.13 | 2.36 | |||
| Total Shareholders' Equity | 477.05M | 534.66M | 360.53M | 191.60M | 117.20M | |||
| TOTAL LIABILITIES AND EQUITY | 613.41M | 666.82M | 389.36M | 216.80M | 130.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.20 | 0.18 | N/A | N/A | N/A | |||
| Current Ratio | 15.53 | 18.63 | 13.74 | 8.63 | 9.89 | |||
| Return On Assets (ROA) | -36.34% | -27.78% | -29.41% | -38.98% | -45.24% | |||
| Return On Equity (ROE) | -46.73% | -34.64% | -31.77% | -44.10% | -50.26% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD